Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03616470 · TERMINATED
Trial details
- NCT number
- NCT03616470
- Sponsor
- GlycoMimetics Incorporated
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2024-03-31
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.